The distribution success that becomes a dependency

## Keep the successful relationship in the argument

A distribution partnership can deserve praise without deserving every additional commitment the business is asked to make. That sounds obvious until a board paper places a strong volume number at the centre of the discussion. The number becomes evidence of execution, evidence of customer access and, by a further step that often goes unexamined, evidence that the next investment should follow the same route. I have made that step myself. The error was not trusting colleagues who had delivered. It was allowing a successful result to answer a question about dependence that the result had not been designed to answer.

At the fictional Vaqruni,₹210 crore of ₹510 crore new-business premium came through one single-premium partnership. Other routes contributed ₹300 crore. Those figures did not show that the partnership was poor business. They showed that a large share of the reported flow arose through one relationship and a particular payment form. A single premium and a recurring premium instalment do not imply identical future cash patterns. Nor does either amount, in isolation, establish profit. Our finance and actuarial colleagues needed room to explain the relevant economics, obligations and assumptions before the commercial proposal became a conclusion.

The strongest case for expanding the partnership was practical. It worked. People on both sides understood how to operate it, and customers were using the route. Building another relationship would consume time and management attention without a similar initial volume. A chief executive should take that argument seriously. Diversification can become an attractive word attached to an expensive collection of weak channels. The purpose of examining concentration is not to punish a successful commercial team or pretend that every new distributor will contribute equally. It is to understand what the company becomes reliant upon and what would change if that reliance were tested.

I therefore wanted the partner's strengths and the dependency in the same paper. The discussion had to include what we would continue, what we would expand and what we would learn before committing further. Treating those as separate decisions made it possible to retain a valuable relationship without accepting the whole proposed expansion immediately. It also made disagreement more productive. Colleagues did not have to choose between defending their achievement and admitting a concentration. Both could be true. The executive task was to hold them together long enough to make a proportionate commercial decision.

## Distinguish an alternative route from alternative flow

Our ₹1.7 crore programme funded analysis and the development of additional distribution routes. That was an expense incurred for a strategic purpose, not proof that concentration had already fallen. Signing an agreement creates an option to do business. It does not create customers, premium flow, operating familiarity or an enduring commercial relationship. I wanted those stages kept separate in subsequent reporting. Otherwise the diversification programme would produce its own simplified success story, replacing one oversized number with another: the count of partners appointed rather than the source of business actually written through them.

This distinction matters to the people doing the work. If every new route is expected to match the established partner quickly, teams may overpromise in negotiation or select business for the appearance of early volume. If no contribution is expected for an indefinite period, the programme can become insulated from commercial scrutiny. Management needs a credible account of how a route develops, what it costs and which evidence would justify further investment. That account should include the operating burden of supporting a different channel. An additional relationship can diversify access while increasing complexity elsewhere in the organisation.

At our next review, two additional routes were operating but had not removed the original concentration. That was an incomplete outcome, and I wanted it described as such. We could show actual flows separately from contracted capacity and explain what had been learned. We could not say the strategic risk had disappeared merely because the programme had delivered its first milestones. The board also needed to retain the cost of ₹1.7 crore in its view. A smaller commitment to the original expansion was not automatically a cash saving; it was a different decision about future deployment, with its own opportunity cost.

The same reasoning applies when a business considers a highly productive distributor in another sector. The useful questions concern the relationship's contribution, the terms of dependence and the practical credibility of alternatives. They do not begin with a universal maximum share. A percentage can prompt enquiry, but the consequences depend on how the channel works, what customers expect and what another route could genuinely replace. In life insurance, professional assessment of the obligations written remains essential. A distribution strategy cannot be judged only by the speed at which it collects premium or the number of logos in a presentation.

## Make the executive summary carry the difficult distinction

I had asked for a concise growth chart because the board needed to make several decisions in limited time. Concision was a reasonable objective. The problem was what we removed to achieve it. The distinction between the ₹210 crore partnership flow and the ₹300 crore from other routes was central to the decision, yet the summary made it secondary. A well-designed executive paper should reduce unnecessary detail while preserving the categories that change judgement. It should not require a director to reconstruct the business from appendices before recognising the main dependency in the proposed plan.

That responsibility belongs partly to the chief executive. We influence the shape of the answer by the question we ask and the kind of confidence we reward. If the only welcome response to a strong result is an unqualified plan for more, colleagues learn to place complications later in the discussion. I want commercial leaders to know that explaining a limit does not diminish an achievement. It can make the next recommendation more credible. The partner can remain a success while the proposed pace of expansion changes. That is a more demanding account of leadership than choosing between enthusiasm and caution.

There is also a continuing test after the decision. A staged plan should specify what will be revisited, by whom and with what evidence. It should not make every future step dependent on a vague feeling of comfort. Equally, reaching a numerical milestone should not automatically authorise expansion if the underlying composition has changed. I would expect management to explain a material shift rather than rely on the original approval's language. The board's role is to assess that account and the consequences of the proposed choice; it is not to become the day-to-day manager of each distributor relationship.

My conclusion is practical: preserve the source of the success in the explanation of the next decision. Show the contribution of the large partner, the obligations associated with the business and the actual development of alternatives. Recognise the value of a working relationship without treating dependence as an embarrassing detail. At Vaqruni, that meant a smaller immediate expansion, a funded programme and an unfinished diversification account. Another company may reasonably choose a different pace. What it should not have to accept is a total so polished that it hides the judgement the board was assembled to make.